Iradimed specializes in developing MRI-compatible medical devices, including the MRidium® IV infusion pump system, which operates safely in MRI environments and eliminates risks associated with ...

IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that it will participate in the 37th Annual Roth Conference. Iradimed’s CFO, Jack Glenn, and CCO, Jeff Chiprin, will host one-on-one ...

We are the only provider of a non-magnetic intravenous (“IV”) infusion pump system designed to be safe during MRI procedures. We were the first to develop an infusion delivery system that ...

StockNews.com cut shares of Iradimed (NASDAQ:IRMD – Free Report) from a strong-buy rating to a buy rating in a research report report published on Tuesday. Separately, Roth Mkm reaffirmed a “buy” ...

The intravenous infusion pumps market is set to grow from US$ 6.2 Bn in 2024 to US$ 11.4 Bn by 2031, registering a CAGR of 8.5% during 2024-2031. LOS ANGELES, CA, UNITED STATES, February 13 ...

Baxter Healthcare has issued a recall for some Spectrum infusion pumps due to a potential defect involving missing motor mounting screws, which could lead to interruptions, delays or incorrect ...

Browse For More Similar Reports- Intravenous Infusion Pumps Global Market Report 2025 Ambulatory IV infusion Pumps Global Market Report 2025 Implantable Infusion Pumps Global Market Report 2025 ...

IV treatment ... enabled, infusion therapy being one of the fundamental elements of modern healthcare, continues to evolve. Not surprising that medical devices such as infusion pumps, infusion ...